KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Align Technology (ALGN) Gains from Sales and Divestitures (2009 - 2012)

Align Technology (ALGN) reported Gains from Sales and Divestitures of $320000.0 for Q1 2012, down 23.21% on a QoQ basis from $416735.0 in Q4 2011.

Align Technology (ALGN) has 4 years of Gains from Sales and Divestitures data on file, last reported at $320000.0 in Q1 2012.

  • Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $320000.0 in Q1 2012, while the trailing twelve-month figure through Mar 2012 was $320000.0 (changed N/A YoY) and the FY2011 annual result came in at $416735.0, up 27.44% from the prior year.
  • Gains from Sales and Divestitures retreated to $320000.0 in Q1 2012 per ALGN's latest filing, from $416735.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $416735.0 in Q4 2011 and bottomed at $257000.0 in Q4 2009.
  • The 4-year median for Gains from Sales and Divestitures is $344500.0 (2010), against an average of $342955.8.
  • The widest annual swing landed in 2010, when Gains from Sales and Divestitures rose 27.24%; it then rose 27.44% in 2011.
  • Tracing ALGN's Gains from Sales and Divestitures over 4 years: stood at $257000.0 in 2009, then increased by 27.24% to $327000.0 in 2010, then climbed by 27.44% to $416735.0 in 2011, then decreased by 23.21% to $320000.0 in 2012.
  • Per Business Quant, the three latest ALGN Gains from Sales and Divestitures figures stand at $320000.0 (Q1 2012), $416735.0 (Q4 2011), and $375000.0 (Q3 2011).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2012 320,000.00
Mar 31, 2012 320,000.00
Dec 31, 2011 416,735.00
Dec 31, 2011 416,735.00
Sep 30, 2011 375,000.00
Sep 30, 2011 375,000.00
Jun 30, 2011 362,000.00
Jun 30, 2011 362,000.00
Dec 31, 2010 327,000.00
Dec 31, 2010 327,000.00
Dec 31, 2009 257,000.00
Dec 31, 2009 257,000.00